- Most Recent Funding
- $6.9 Million on April 11, 2014 / Undisclosed Round
Cellular Biomedicine Group (OTCQB: CBMG) is a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases utilizing proprietary cell therapy technologies. We are the result of the acquisition, transfer, commercialization and advancement of thirty years of research and human treatment experience in cellular medicine. Our cellular research and development is the result of collaboration among scientists and doctors from the US, England and China.
530 University Avenue
Palo Alto, CA 94301
- 08/06/14 -chinabiotoday.com